Dr. Stephen M. Stahl discusses the relaunch of the journal CNS Spectrums with Cambridge University Press.

Editor-in Chief

Dr Stephen M. Stahl
University of California San Diego, School of Medicine, USA
Psychopharmacologic treatment of resistant cases; Neurology

Field Editors

Dr Terence Arthur Ketter
Stanford University School of Medicine, USA
Psychiatry; mood disorders, particularly bipolar disorder; psychopharmacology; brain imaging; creativity; psychiatric phenomenology

Dr Gerard Sanacora
Yale University School of Medicine, USA
Translation neuroscience; stress; glutamate; magnetic resonance spectroscopy; treatment-resistant mood disorders

Editorial Board

Dr Terence Arthur Ketter
Stanford University School of Medicine, USA
Psychiatry; mood disorders, particularly bipolar disorder; psychopharmacology; brain imaging; creativity; psychiatric phenomenology

Thilo Deckersbach

Dr Thomas L. Schwartz
SUNY Upstate Medical University, USA
Psychopharmacology; clinical trial research experience in treatment-resistant depression; anxiety disorders; and psychosomatic illness

Dr Carlos A. Zarate, Jr.
National Institute of Mental Health, USA
Major depressive disorders; bipolar disorder; mood disorders; proof-of-concept studies; glutamate

Content Editor

Lisa Arrington
Cambridge University Press, USA

Editorial Board

Dr Irismar Reis de Oliveira
Federal University of Bahia, Brazil
General psychopharmacology and interface with cognitive behavioral therapy

Dr Peter P. Roy-Byrne
University of Washington School of Medicine, USA
Anxiety and panic disorders; PTSD; adult ADHD; bipolar disorder

Dr Dennis S. Charney
Mount Sinai School of Medicine, USA
Bipolar disorder; depression; generalized anxiety disorder; panic disorder; post-traumatic stress disorder; psychopharmacology; resilience

Dr Maria Conceição do Rosario
Universidade Federal da Bahia, Brazil
Child psychiatry; obsessive compulsive disorders; (OCD); tic disorders and tourette syndrome; attention deficit hyperactivity disorder (ADHD)

Dr Jeffrey L. Cummings
Cleveland Clinic, USA
Alzheimer's disease; clinical trials; drug development for neurodegenerative diseases

Dr Thomas Cummings
Massachusetts General Hospital, USA
Anxiety and mood disorders (in particular, OCD and bipolar disorder), especially psychiatric neuroimaging (PET and MRI/fMRI); clinical trials regarding MDD and OCD

Dr Koen Demyttenaere
University Psychiatric Center KuLeuven - Campus Gasthuisberg, Belgium
Antidepressants, mood disorders, anxiety disorders, personality disorders, somatoform disorders, eating disorders, sexual disorders

Dr Karen Ersche
University of Cambridge, UK
Cognitive dysfunction; personality traits and neurobiological changes associated with drug addiction and addiction recovery

Dr Robert L. Findling
Case Western Reserve University, USA
Child and adolescent psychiatry

Dr Mark George
Medical University of South Carolina, USA
Neurology; brain stimulation

Dr Eric Hollander
Montefiore Medical Center, USA
Neuropharmacology; neuropsychiatry; functional imaging, and pharmacological treatment of obsessive-compulsive disorder and obsessive-compulsive-related disorders such as body dysmorphic disorder; impulsive/aggressive personality disorders and impulse control disorders such as pathological gambling; autism; and autism spectrum disorders

Dr Daphne Holt
Massachusetts General Hospital, USA
Schizophrenia; neuroscience; brain imaging; emotion

Dr Peter Jones
University of Cambridge, UK
Clinical psychiatry; clinical epidemiology

Dr Andres M. Kanner
University of Miami, Miller School of Medicine, USA
Epilepsy; pharmacologic treatment of epilepsy; psychiatric aspects of epilepsy; surgical treatment of epilepsy; comorbid disorders of epilepsy; mood disorders; neurobiologic aspects of mood disorders; treatment of mood disorders; depressive disorders in neurologic illness; anxiety disorders

Dr Anthony D. Loebel
New York University School of Medicine , USA
Psychiatry; psychopharmacology

Dr Donatella Marazziti
University of Pisa, Italy
OCD; anxiety disorders; mood disorders; biologicalpsychiatry; psychopharmacology

Dr Herbert Meltzer
Northwestern University, USA
Schizophrenia; psychopharmacology; antipsychotic drug development; cognition; depression; anxiety; eating disorders; bipolar disorder

Dr Mario F. Mendez
Veterans’ Affairs Neurobehavior Unit, USA
Behavioral neurology; cognitive disorders, especially frontotemporal dementia and early onset dementias; unusual brain-behavior disorders; social neuroscience

Dr Philip Mitchell
University of New South Wales, Australia
Bipolar disorder; transcranial magnetic stimulation; treatment-resistant depression; genetics; major depressive disorder

Dr Jun Nakamura
University of Occupational and Environmental Health, Japan
General psychopharmacology

Dr Humberto Nicolini
National Institutes of Health, Minister of Health, (Mexico)
Genetics; addictions; OCD; psycopharmacology; hispanic population

Dr Andrew A. Nierenberg
Massachusetts General Hospital, USA
Depression; bipolar disorder; treatment-resistant depression

Dr Stefano Pallanti
University of Florence, Italy, Italy
OCD; impulsive and behavioral addiction; depression and psychosis; anxiety; treatment trials; adult ADHD and autism

Dr Katharine A. Phillips
Brown Medical School, USA
Treatment and psychopathology of body dysmorphic disorder (BDD), olfactory reference syndrome, and obesessive-compulsive disorder (OCD)

Dr Diego Pizzagalli
Harvard University, USA
Reward circuitry; depression; neuroimaging; mood disorders; stress

Dr Mark H. Pollack
Rush University Medical Center, USA
Anxiety disorders; panic disorder; phobias; posttraumatic stress disorder; psychopharmacology

Dr Mark H. Rapaport
Emory University, USA
Anxiety; depression; immunology; outcomes

Dr Trevor W. Robbins
University of Cambridge, UK
Cognitive neuroscience, behavioural neuroscience; neuropsychopharmacology; learning and memory executive functions; frontal lobe; striatum; and limbic system; dopamine, noradrenaline, and serotonin issues; addiction; cognitive enhancement; dementia; ADHD; OCD; schizophrenia; depression; Parkinson's, Huntington's and Alzheimer's disease

Dr Barbara J. Sahakian
University of Cambridge, UK
Cognitive psychopharmacology; neuroethics; neuropsychology; neuropsychiatry and neuroimaging; women in neuroscience; neuroethics; engagement of the public in science and neuroscience and mental health policy

Dr Alan F. Schatzberg
Stanford University School of Medicine, USA
Anxiety and depressive disorders (major depression; chronic depression, non-delusional depression); pharmacogenetics; functional imaging, and psychotic major depression

Dr Thomas Schlaepfer
University of Bonn, Germany
Brain stimulation; deep brain stimulation; vagus nerve stimulation; repetitive transcranial magnetic stimulation; magnetic seizure therapy

Dr Jordan W. Smoller
Massachusetts General Hospital, USA
Psychiatric genetics

Dr Dan J. Stein
University of Cape Town, South Africa
Psychobiology and management of the anxiety disorders, including obsessive-compulsive disorder, posttraumatic stress disorder, and social anxiety disorder

Dr Stephen Strakowski
University of Cincinnati, USA
Schizophrenia; bipolar disorder; psychotic disorders; neuroimaging

Dr T. Scott Stroup
Columbia University, USA
General psychiatry; schizophrenia

Dr Frank I. Tarazi
Harvard Medical School, USA
Alzheimer's Disease, schizophrenia, bipolar disorder, depression, ADHD, insomnia and Huntington's disease.

Dr Michael Thase
University of Pennsylvania, USA
Assessment and treatment of mood disorders, with particular interest in major depressive disorders; long-term treatment and combination therapy

Dr Michael R. Trimble
National Hospital for Neurology & Neurosurgery, UK
Neurology and psychiatry; neuropsychiatry and behavioural neurology; head injury, with special reference to epilepsy and behavioural problems; post-traumatic stress disorder; functional neurologic disorder; conversion disorder; dissociation disorder; factitious disorder/malingering; tics (involuntary, brief, stereotyped motor and vocal actions; symptoms of tourette syndrome (TS); attention deficit hyperactivity disorder (ADHD); medical negligence in relation to the development of psychiatric illness; the use of anticonvulsant drugs in psychiatry; epilepsy (including the effects of seizures and the impact of epilepsy treatment on human behaviour); disorders of the limbic system; personality disorders and neuroses; schizophrenia; dementias

Dr Madhukar H.  Trivedi
University of Texas Southwestern Medical Center, USA
Mood disorders; major depressive disorder; bipolar disorder

Dr Karen Dineen Wagner
The University of Texas Medical Branch, USA
Mood and anxiety disorders in child and adolescent psychiatry

Dr Katherine Warburton
California Department of State Hospitals, USA
Forensic psychiatry, forensic public mental health systems, assessment and treatment of aggression and competency restoration

Dr Stephen Wisniewski
University of Pittsburgh, USA
Bipolar disorder; treatment-resistant depression; chronic depression; statistics and study design; clinical trials

Dr Shigeto Yamawaki
Hiroshima University, USA
OCD; mood and anxiety disorders

Dr Joseph Zohar
Chaim Sheba Medical Center, Israel
Anxiety and mood disorders